FDA approves Medtronic’s adaptive deep-brain stimulator for Parkinson’s disease

Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the FDA’s approval for its adaptive, closed-loop neurostimulation approach to treating the motor symptoms that come with Parkinson’s disease.